No Data
Are LifeTech Scientific Corporation's (HKG:1302) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
China's Medical Device Market Value Hits $179B, 90th CMEF in Shenzhen to Feature a Plethora of Technological Products
Sinolink Securities: The pharmaceutical sector is expected to see an improvement in market conditions in the third quarter, and overall growth expectations for the second half of the year are optimistic.
Sinolink Securities released a research report stating that considering the improvement in the medical insurance settlement cycle, the expectation of policy improvement, and the recovery performance of the industry, as well as the fact that institutional medicine hold positions are at a low level, the medical sector will usher in an improved market situation in Q3.
LIFETECH SCI: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THEANNUAL RESULTS ANNOUNCEMENT AND ANNUAL REPORTFOR THE YEAR ENDED 31 DECEMBER 2023
Lifetech sci purchased 66 million shares according to the stock incentive plan.
Lifetech Sci (01302) announced that on June 27, 2024, the trustee, the seller and the company entered into the agreement. In terms of the stock incentive plan, the trustee (at the direction of the company) agreed to purchase 66 million shares of stock from the seller (with funds provided by the company) at a price of HKD 1.5 per share, for a total price of HKD 99 million. The seller is Xianjian Advanced Technology Limited, which is wholly owned by Mr. Xie Yuehui (executive director and chairman and chief executive officer of the company).
Lifetech Sci (01302.HK) : The trustee purchased 66 million shares under the stock incentive plan.
On June 27, Gelunhui announced that Lifetech Sci (01302.HK) had entered into an agreement on June 27, 2024, in which the trustee, the seller, and the company agreed that the trustee (as instructed by the company) agreed to purchase (funds provided by the company) and the seller agreed to sell 66 million shares of stock as part of the share incentive plan.
LifeTech Scientific Corporation (HKG:1302) May Have Run Too Fast Too Soon With Recent 27% Price PlummetNo Data
